Clinical Trial Update: Efficacy and Safety of Lusutrombopag After Allogeneic Hematopoietic Stem Cell Transplantation [NA]

View source ↗

Summary

A clinical trial is evaluating the efficacy and safety of lusutrombopag in patients with hematologic disorders after allogeneic hematopoietic stem cell transpla…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Disorders

Drugs mentioned

• lusutrombopag (lusutrombopag)

Snippet

Sponsor: The General Hospital of Western Theater Command | Conditions: Patients With Hematologic Disorders After Allogeneic Hematopoietic Stem Cell Transplantation, Hematologic Disorders | NA | Status: RECRUITING